Deltasone and Rinvoq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Deltasone (prednisone) and Rinvoq (upadacitinib). Common drug interactions include dry skin among females and atelectasis among males.

The phase IV clinical study analyzes what interactions people have when they take Deltasone and Rinvoq. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Deltasone?

Deltasone has active ingredients of prednisone. eHealthMe is studying from 4,243 Deltasone users. Check the latest studies of Deltasone.

What is Rinvoq?

Rinvoq has active ingredients of upadacitinib. eHealthMe is studying from 47,375 Rinvoq users. Check the latest studies of Rinvoq.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

12 people who take Deltasone and Rinvoq together, and have interactions are studied.

What are the common drug interactions of Deltasone and Rinvoq, by gender? *:

female:

Dry skin
Oedema (fluid collection in tissue)
Osteopenia (a condition where bone mineral density is lower than normal)
Pulmonary embolism (blockage of the main artery of the lung)
Swelling
Wrist fracture
Hospitalisation
Rash
Anxiety
Balance disorder

male:

Atelectasis (partial or complete collapse of the lung)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Drug ineffective
Pericardial effusion (fluid around the heart)
Pleural fibrosis (formation of fibrous tissue in lung)
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Deltasone and Rinvoq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drug ineffective
Hypergammaglobulinaemia benign monoclonal (elevated levels of gamma globulin)
Blood calcium increased

50-59:

n/a

60+:

Hospitalisation
Colorectal cancer (colon cancer or bowel cancer)
Dry skin
Skin warm
Synovitis (inflammation of the synovial membrane)
Wheezing (a high-pitched whistling sound made while you breath)
Malaise (a feeling of general discomfort or uneasiness)
Pneumonia
Rash

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 50.00%
Pain: 3 people, 25.00%
Senile Osteoporosis (weak bones with ageing): 1 person, 8.33%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 8.33%
Rashes (redness): 1 person, 8.33%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 8.33%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 8.33%
Itching: 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Deltasone and Rinvoq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously